Showing results (41-50 of 54) with videos related to
Sort By:
Pageof 6
Neuro-Oncology Practice|August 7, 2019
The association of health-related quality of life and cognitive function in patients receiving memantine for the prevention of cognitive dysfunction during whole-brain radiotherapyNadia N Laack, Stephanie L Pugh, Paul D Brown, et al.Technology in Cancer Research & Treatment|April 2, 2009
The impact of hybrid PET-CT scan on overall oncologic management, with a focus on radiotherapy planning: a prospective, blinded studyTim J Kruser, Kristin A Bradley, Soren M Bentzen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2014
Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234Paul M Harari, Jonathan Harris, Merrill S Kies, et al.International Journal of Radiation Oncology, Biology, Physics|February 10, 2015
Phase 1 trial of bevacizumab with concurrent chemoradiation therapy for squamous cell carcinoma of the head and neck with exploratory functional imaging of tumor hypoxia, proliferation, and perfusionMatthew J Nyflot, Tim J Kruser, Anne M Traynor, et al.JMIR Research Protocols|October 7, 2022
FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases (FAST-01): Protocol for the First Prospective Feasibility StudyEmily C Daugherty, Anthony Mascia, Yong Zhang, et al.Journal of Neuro-Oncology|October 22, 2013
Single institution experience treating 104 vestibular schwannomas with fractionated stereotactic radiation therapy or stereotactic radiosurgeryBethany M Anderson, Deepak Khuntia, Søren M Bentzen, et al.Neuro-Oncology|August 20, 2013
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trialPaul D Brown, Stephanie Pugh, Nadia N Laack, et al.International Journal of Radiation Oncology, Biology, Physics|February 9, 2013
A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320Paul W Sperduto, Meihua Wang, H Ian Robins, et al.International Journal of Radiation Oncology, Biology, Physics|December 15, 2023
Impact of Apolipoprotein E Genotype on Neurocognitive Function in Patients With Brain Metastases: An Analysis of NRG Oncology's RTOG 0614Jeffrey S Wefel, Snehal Deshmukh, Paul D Brown, et al.The Lancet. Oncology|July 9, 2017
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trialPaul D Brown, Karla V Ballman, Jane H Cerhan, et al.Pageof 6